| __timestamp | BioCryst Pharmaceuticals, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 11947000000 |
| Thursday, January 1, 2015 | 46361000 | 12651000000 |
| Friday, January 1, 2016 | 23654000 | 14481000000 |
| Sunday, January 1, 2017 | 23484000 | 14710000000 |
| Monday, January 1, 2018 | 20182000 | 16014000000 |
| Tuesday, January 1, 2019 | 44734000 | 18067000000 |
| Wednesday, January 1, 2020 | 16136000 | 30745000000 |
| Friday, January 1, 2021 | 149906000 | 36445000000 |
| Saturday, January 1, 2022 | 264233000 | 36022000000 |
| Sunday, January 1, 2023 | 326751000 | 34313000000 |
| Monday, January 1, 2024 | 36351000000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, understanding financial trends is crucial. This chart compares the gross profit trajectories of Bristol-Myers Squibb Company and BioCryst Pharmaceuticals, Inc. over the past decade.
From 2014 to 2023, Bristol-Myers Squibb has shown a robust growth in gross profit, peaking in 2021 with a staggering 36.4 billion. Despite a slight dip in 2023, their profits remain strong, reflecting their strategic market positioning and successful product lines.
BioCryst Pharmaceuticals, though smaller, has demonstrated impressive growth, particularly from 2020 onwards. Their gross profit surged by over 1,900% from 2014 to 2023, highlighting their innovative approach and expanding market presence.
This comparison underscores the diverse strategies and market dynamics within the pharmaceutical sector, offering valuable insights for investors and industry analysts.
Novo Nordisk A/S vs Bristol-Myers Squibb Company: A Gross Profit Performance Breakdown
Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc
Bristol-Myers Squibb Company and Perrigo Company plc: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Pharming Group N.V. or BioCryst Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown